Anzeige
Mehr »
Login
Donnerstag, 30.01.2025 Börsentäglich über 12.000 News von 684 internationalen Medien
Absoluter Geheimtipp: Vergessen Sie Gold, Silber und Uran!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NC7B | ISIN: US92826C8394 | Ticker-Symbol: 3V64
Tradegate
29.01.25
21:57 Uhr
322,75 Euro
+0,05
+0,02 %
1-Jahres-Chart
VISA INC Chart 1 Jahr
5-Tage-Chart
VISA INC 5-Tage-Chart
RealtimeGeldBriefZeit
322,55323,2029.01.
322,20323,1529.01.
GlobeNewswire (Europe)
481 Leser
Artikel bewerten:
(2)

Fingerprint Cards AB: Infineon's SECORA Pay Bio solution, using Fingerprints' biometric technology, receives full Visa certification

Finanznachrichten News

Infineon Technologies AG, a global payment market leader and Fingerprint Cards AB, a global leader in biometric technology, are proud to announce that SECORA Pay Bio has recently received certification by Visa. Infineon's SECORA Pay Bio payment card solution, integrating Fingerprints' FPC1323 sensor, is now fully certified for use in Visa and Mastercard payment cards, marking a significant milestone in the companies' missions to provide secured and seamless payments.

The fully certified biometric payment solution leverages Fingerprints' advanced fingerprint recognition technology with Infineon's industry leading secured enclave to offer enhanced security and convenience for users.

Key Features of the certified SECORA Pay Bio Payment Solution:

  • Seamless User Experience: The biometric payment solution offers a touchless experience, increasing convenience and transaction speeds, while being more hygienic.
  • Enhanced Security: The solution offers strong 2-factor authentication, with biometric technology, as alternative to 4-digit pins.
  • Ready To Use: The product is designed to integrate effortlessly with existing payment infrastructures, making it easy for banks and financial institutions to adopt.

Having certification across both Visa and Mastercard further solidifies the global leadership position of both Infineon and Fingerprints in the biometric payments card sector. As part of the expanding partnership, Infineon has placed a volume order for sensors from Fingerprints, due for delivery this year.

Adam Philpott, CEO, Fingerprint Cards, said:
" Achieving Mastercard and Visa certification for SECORA Pay Bio using Fingerprints' technology underscores our technology leadership and commitment to innovation and security in the payment industry. It's also another leap forward in establishing the biometric payment card market. Our biometric payment solution not only enhances security, but also provides a frictionless and convenient user experience. Infineon's recent order also reflects their own commitment to the biometric payment cards sector - they continue to be a great partner to work alongside."

Tolgahan Yildiz, Head of the Trusted Mobile Connectivity and Transactions Product Line, Infineon Technologies, said:
"Thanks to the certification of our turnkey integrated solution we are enabling our customers with a very simple and accelerated approval and onboarding process. This is an important milestone in our journey to enable simple, scalable and cost-efficient implementations of biometric payment cards. SECORA Pay Bio is designed with attention to detail to eliminate complexities in design and manufacturing of the cards and to simplify biometric enrollment for frictionless consumer journey. We are now gearing up in our collaboration with Fingerprints to bring first projects to success."

For more information about SECORA Pay Bio, visit SECORA Pay Bio security solutions - Infineon Technologies.

For further information, please contact:
Adam Philpott, President & CEO

Investor Relations: +46(0)10-172 00 10, investrel@fingerprints.com

Press: +46(0)10-172 00 20, press@fingerprints.com

About Fingerprints
Fingerprint Cards AB (Fingerprints) - the world's leading biometrics company, with its roots in Sweden. We believe in a secure and seamless universe, where you are the key to everything. Our solutions are found in hundreds of millions of devices and applications, and are used billions of times every day, providing safe and convenient identification and authentication with a human touch. For more information visit our website, read our blog, and follow us on X. Fingerprints is listed on Nasdaq Stockholm (FING B).


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.